Charter Communications Inc vs Medpace Holdings Inc — how do they compare? Charter Communications Inc trades at $151.3 (market cap $18.81B), while Medpace Holdings Inc trades at $601.1 (market cap $16.90B). The key difference: Charter Communications Inc and Medpace Holdings Inc are close in size by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Charter Communications Inc nearer its low. Which is the better fit depends on your goals.
| CHTR | MEDP | |
|---|---|---|
Market Cap | $18.81B | $16.90B |
Sector | Media | Technology |
52-Week High | $282.74 | $620.59 |
52-Week Low | $123.31 | $393.42 |
Enterprise Value | $115.01B | $16.52B |
Signals from Pluang's Aura AI — not financial advice
Charter Communications (CHTR) trades at $149.86, down 2.24% on the day, with a bullish technical signal from moving averages but bearish oscillators. The stock exhibits low valuation multiples with a P/E of 4.1 and P/S of 0.37, while profitability remains solid with a 9.05% net income margin. Recent Q2 2026 earnings beat estimates, though revenue declined year-over-year, and the company has been active in debt management, pricing $4.75 billion in senior secured notes in early August 2026.
The outlook is mixed; the low valuation presents a potential opportunity, but risks include persistent broadband subscriber losses, high debt levels, and competitive pressures. Analyst consensus leans slightly bullish with a $166.18 price target, though sentiment is cautious due to operational headwinds. The stock's trajectory hinges on reversing subscriber trends and managing leverage effectively.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Trailing returns across standard periods
Latest headlines on both assets
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
Read more on CHTR →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →